you will probably Ranitidine Side Effects Overview Side Effects Dosage Professional Tips More Interactions Pregnancy Warnings Breastfeeding Warnings User Reviews Drug Images Support Group Q & A Compare Alternatives Pricing & Coupons For the Consumer Applies to ranitidine: oral solution, oral tablets and tablets for, oral tablets effervescent for solution, parenteral injection, parenteral injection for iv infusion only Side effects include: Oral or parenteral therapy: Headache, sometimes severe. IM therapy: Transient pain at injection site. IV therapy: Transient local burning or itching. For Healthcare Professionals Applies to ranitidine: compounding powder, injectable solution, intravenous solution, oral capsule, oral granule effervescent, oral syrup, oral tablet, oral tablet effervescent General The most commonly reported side effect for IM administration was injection site pain, and the most commonly reported side effects with IV administration were localized pain and burning. [ Ref ] Gastrointestinal Uncommon (0.1% to 1%): Abdominal discomfort/pain, constipation, nausea, vomiting Very rare (less than 0.01%): Acute pancreatitis, diarrhea [ Ref ] Abdominal pain, constipation, and nausea tended to improve with continued treatment. [ Ref ] Cardiovascular Rare (0.01% to 0.1%): Hypotension, chest pain, arrhythmia, bradycardia, atrioventricular block, tachycardia, premature ventricular beats Very rare (less than 0.01%): Asystole, vasculitis [ Ref ] Bradycardia, atrioventricular block, tachycardia, and asystole have occurred in H2 receptor antagonists. [ Ref ] Psychiatric Rare (0.01% to 0.1%): Insomnia, reversible mental confusion, agitation, depression, hallucinations Frequency not reported: Loss of libido [ Ref ] Nervous system Headache may be related to administration of treatment. [ Ref ] Rare (0.01% to 0.1%): Dizziness, somnolence, vertigo, reversible involuntary movement disorders Very rare (less than 0.01%): Headache/severe headache [ Ref ] Dermatologic Rare (0.01% to 0.1%): Urticaria, angioneurotic edema, skin rash Very rare (less than 0.01%): Erythema multiforme, alopecia [ Ref ] Musculoskeletal Very rare (less than 0.01%): Musculoskeletal symptoms, arthralgia, myalgia [ Ref ] Hepatic Rare (0.01% to 0.1%): Transient and reversible changes in liver function tests, increased ALT levels Very rare (less than 0.01%): Hepatocellular/hepatocanalicular/mixed hepatitis with/without jaundice [ Ref ] Hepatitis with/without jaundice were usually reversible. ALT levels increased to at least 2 times the pretreatment levels in patients receiving high IV doses for at least 5 days. [ Ref ] Other Rare (0.01% to 0.1%): Fever, malaise Frequency not reported: Death [ Ref ] Hypersensitivity Rare (0.01% to 0.1%): Hypersensitivity reactions Very rare (less than 0.01%): Anaphylactic shock/anaphylaxis [ Ref ] Anaphylactic shock occurred after administration of a single dose. [ Ref ] Renal Rare (0.01% to 0.1%): Elevation in serum creatinine Very rare (less than 0.01%): Acute interstitial nephritis [ Ref ] Elevation in serum creatinine was usually slight, and typically normalized with continued treatment. [ Ref ] Respiratory Rare (0.01% to 0.1%): Bronchospasm Frequency not reported: Dyspnea, pneumonia [ Ref ] Ocular Rare (0.01% to 0.1%): Reversible blurred vision [ Ref ] Hematologic Very rare (less than 0.01%): Blood count changes, leukopenia, thrombocytopenia, granulocytopenia, agranulocytosis, pancytopenia, marrow hypoplasia/aplasia Frequency not reported: Aplastic anemia, immune hemolytic anemia/acquired immune hemolytic anemia, eosinophilia [ Ref ] Leukopenia, granulocytopenia, and thrombocytopenia were usually reversible. [ Ref ] Genitourinary Very rare (less than 0.01%): Reversible impotence, breast symptoms/conditions, galactorrhea [ Ref ] Endocrine Very rare (less than 0.01%): Gynecomastia [ Ref ] Metabolic Postmarketing reports: Acute porphyria [ Ref ] Local Frequency not reported: Injection site pain, transient localized burning or itching [ Ref ] References 1. "Product Information. Zantac 75 (ranitidine)." Pfizer U.S. Pharmaceuticals, New York, NY. 2. Cerner Multum, Inc. "Australian Product Information." O 0 3. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0 4. "Product Information. Zantac (ranitidine)." Glaxo Wellcome, Research Triangle Park, NC. Some side effects of ranitidine may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA . Next Dosage Print this page More about ranitidine Side Effects During Pregnancy or Breastfeeding Dosage Information Drug Images Drug Interactions Compare Alternatives Support Group Pricing & Coupons En Español 95 Reviews Add your own review/rating Drug class: H2 antagonists Consumer resources Ranitidine Ranitidine Injection Ranitidine Suspension Ranitidine Tablets and Capsules Ranitidine Syrup Other brands: Zantac , Zantac 150 , Zantac 75 , Zantac 300 , ... +2 more Professional resources Ranitidine Hydrochloride (AHFS Monograph) ... +6 more Related treatment guides GERD Gastric Ulcer Maintenance Treatment Duodenal Ulcer Pathological Hypersecretory Conditions ... +11 more Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist. Drug Status Rx OTC Availability Rx and/or OTC B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Manufacturers Amneal Pharmaceuticals LLC Dr. Reddy's Laboratories, Inc. Lannett Company, Inc. Mylan Pharmaceuticals Inc. Sandoz Inc. Wockhardt USA LLC Zydus Pharmaceuticals (USA) Inc. Heritage Pharmaceuticals Inc. Sun Pharmaceutical Industries Inc. Glenmark Pharmaceuticals Inc., USA Nostrum Laboratories, Inc. AvKare, Inc. More... Drug Class H2 antagonists Related Drugs GERD omeprazole , pantoprazole , ranitidine , famotidine , Nexium , Prilosec , More... Erosive Esophagitis omeprazole , pantoprazole , ranitidine , famotidine , Nexium , Prilosec , More... Duodenal Ulcer omeprazole , pantoprazole , ranitidine , famotidine , Prilosec , Protonix , More... Gastric Ulcer Maintenance Treatment ranitidine , Zantac , Zantac 150 , Zantac 75 , Zantac 300 , Deprizine , More... 9 more conditions... Ranitidine Rating 95 User Reviews 7.9 /10 95 User Reviews 7.9 Rate it! Ranitidine Images Ranitidine systemic 150 mg (IP 253 ) View all images grow old
seek advice from Ranitidine Side Effects seems
EmoticonEmoticon